Publications
[29] Zhu H, Han R, Duan DD. (2016) Novel Biomarkers and Treatments of Cardiac Diseases. Biomed Res Int 2016: 1315627. Full Text
[28] Xu J, El Refaey M, Xu L, Zhao L, Gao Y, Floyd K, Karaze T, Janssen PM, Han R*. (2015) Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy. Skelet Muscle 5: 43. Full Text
[27] Xu L, Park KH, Zhao L, Xu J, El Refaey M, Gao Y, Zhu H, Ma J, Han R*. (2015) CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice. Molecular Therapy 24: 564-569. Full Text
[26] Cheng X, Zhang X, Gao Q, Ali Samie M, Azar M, Tsang WL, Dong L, Sahoo N, Li X, Zhuo Y, Garrity AG, Wang X, Ferrer M, Dowling J, Xu L, Han R, Xu H. (2014) The intracellular Ca2+ channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophy. Nature Medicine 20: 1187-1192. Full Text
[25] Meng Z, Han R, Hu Y, Yuan Z, Jiang S, Zhang X, Xu J. (2014) Possible pandemic threat from new reassortment of influenza A(H7N9) virus in China. Euro Surveill 19: pii: 20699. Full Text
[24] Mariano A, Xu L, Han R*. (2014) Highly efficient genome editing via 2A-coupled co-expression of two TALEN monomers. BMC Res Notes 7: 628. Full Text
[23] Zhao P, Torcaso A, Mariano A, Xu L, Mohsin S, Zhao L, Han R*. (2014) Anoctamin 6 regulates C2C12 myoblast proliferation. PLoS One 9: e92749. Full Text
[22] Iyer SS, He Q, Janczy JR, Elliott EI, Zhong Z, Olivier AK, Sadler JJ, Knepper-Adrian V, Han R, Qiao L, Eisenbarth SC, Nauseef WM, Cassel SL, Sutterwala FS. (2013) Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39: 311-323. Full Text
[21] Lin B, Govindan S, Lee K, Zhao P, Han R, Runte KE, Craig R, Palmer BM, Sadayappan S. (2013) Cardiac myosin binding protein-C plays no regulatory role in skeletal muscle structure and function. PLoS One 8: e69671. Full Text
[20] Xu L, Zhao P, Mariano A, Han R*. (2013) Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases. Molecular Therapy Nucleic Acids 2: e112. Full Text
[19] Mariano A, Henning A, Han R*. (2013) Dysferlin-deficient muscular dystrophy and innate immune activation. FEBS J 280: 4165-4176. Full Text
[18] Zhong Z, Zhai Y, Liang S, Mori Y, Han R, Sutterwala FS, Qiao L. (2013) TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nature Communations 4: 1611. Full Text
[17] Wu J, Meng Z, Xu J, Lei Y, Jin L, Zhong P, Han R, Su B. (2013) New emerging recombinant HIV-1 strains and close transmission linkage of HIV-1 strains in the Chinese MSM population indicate a new epidemic risk. PLoS One 8: e54322. Full Text
[16] Han R, Rader EP, Levy JR, Bansal D, Campbell KP. (2011) Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice. Skelet Muscle 1: 35. Full Text
[15] Xu L, Pallikkuth S, Hou Z, Mignery GA, Robia SL, Han R*. (2011) Dysferlin forms a dimer mediated by the C2 domains and the transmembrane domain in vitro and in living cells. PLoS One 6: e27884. Full Text
[14] Han R, Kobuke K, Anderson M, Beltran-Valero de Bernabe D, Kobayashi Y, Yang B, Campbell KP. (2011) Improved genotyping of the dysferlin-null mouse. Protocol Exchange doi: 10.1038/protex.2011.232.. Full Text
[13] Zhao P, Xu L, Ait-Mou Y, de Tombe PP, Han R*. (2011) Equal force recovery in dysferlin-deficient and wild-type muscles following saponin exposure. J Biomed Biotechnol 2011: 235216. Full Text
[12] Han R*. (2011) Muscle membrane repair and inflammatory attack in dysferlinopathy. Skelet Muscle 1: 10. Full Text
[11] Han R, Frett EM, Levy JR, Rader EP, Lueck JD, Bansal D, Moore SA, Ng R, Beltran-Valero de Bernabe D, Faulkner JA, Campbell KP. (2010) Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. J Clin Invest 120: 4366-4374. Full Text
[10] Han R, Kanagawa M, Yoshida-Moriguchi T, Rader EP, Ng RA, Michele DE, Muirhead DE, Kunz S, Moore SA, Iannaccone ST, Miyake K, McNeil PL, Mayer U, Oldstone MB, Faulkner JA, Campbell KP. (2009) Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. PNAS 106: 12573-12579. Full Text
| First | Previous | Next | Last |